Breast milk oligosaccharides: Structure-function relationships in the neonate

Annual Review of Nutrition

Volumn 34, Issue , 2014, Pages 143-169

  Smilowitz, Jennifer T ^a   Lebrilla, Carlito B ^a   Mills, David A ^a   German, J Bruce ^a   Freeman, Samara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bifidobacteria; Breast milk glycans; Glycomics; Immunity; Intestinal barrier function

Indexed keywords

GLYCAN; GLYCOLIPID; GLYCOPEPTIDE; GLYCOPROTEIN; OLIGOSACCHARIDE; PREBIOTIC AGENT; MILK PROTEIN;

ARTICLE; BIFIDOBACTERIACEAE; BLOOD GROUP LEWIS SYSTEM; BREAST MILK; CARBOHYDRATE ANALYSIS; CHILD NUTRITION; GESTATIONAL AGE; GLYCOBIOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFANT; INTESTINE FLORA; LACTATION; MAMMARY GLAND; MATERNAL WELFARE; MICROBIOME; NEWBORN; NONHUMAN; NUTRITION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; BIFIDOBACTERIUM; BIOLOGICAL MODEL; BREAST FEEDING; CHEMISTRY; CHILD DEVELOPMENT; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; MALE; METABOLISM; MICROBIOLOGY;

BIFIDOBACTERIUM; BREAST FEEDING; CARBOHYDRATE SEQUENCE; CHILD DEVELOPMENT; FEMALE; GLYCOLIPIDS; GLYCOPEPTIDES; GLYCOPROTEINS; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; INTESTINAL MUCOSA; LACTATION; MALE; MILK PROTEINS; MILK, HUMAN; MODELS, BIOLOGICAL; OLIGOSACCHARIDES;

EID: 84904670467     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071813-105721     Document Type: Article

References (152)

1. AlfalehK, Anabrees J, Bassler D, Al-Kharfi T. 2011. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 3:CD005496
2. Alvarez-Manilla G, Atwood J III, Guo Y, Warren NL, Orlando R, Pierce M. 2006. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. J. Proteome Res. 5:701-8
3. Am. Diabetes Assoc. 2011. Diagnosis and classification of diabetes mellitus. Diabetes Care 34:S62-69
4. An HJ, Froehlich JW, Lebrilla CB. 2009. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr. Opin. Chem. Biol. 13:421-26
5. Andersson B, Porras O, Hanson LA, Lagergard T, Svanborg-Edn C. 1986. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. J. Infect. Dis. 153:232-37
6. Aoki-Kinoshita KF. 2008. An introduction to bioinformatics for glycomics research. PLoS Comput. Biol. 4:e1000075
7. AshlineD, Singh S, Hanneman A, Reinhold V. 2005. Congruent strategies for carbohydrate sequencing. Mining structural details by MSn. Anal. Chem. 77:6250-62
8. Azuma N, Yamauchi K, Mitsuoka T. 1984. Bifidus growth-promoting activity of a glycomacropeptide derived from human K-casein. Agric. Biol. Chem. 48:2159-62
9. BarbozaM, Pinzon J,Wickramasinghe S, Froehlich JW,Moeller I, et al. 2012. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteriahost interactions. Mol. Cell Proteomics 11:M111.015248
10. Barboza M, Sela DA, Pirim C, Locascio RG, Freeman SL, et al. 2009. Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Appl. Environ. Microbiol. 75:7319-25
11. Barile D, Marotta M, Chu C, Mehra R, Grimm R, et al. 2010. Neutral and acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of lactation measured by high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. J. Dairy Sci. 93:3940-49
12. Bellamy L, Casas JP, Hingorani AD, Williams D. 2009. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773-79
13. Blackburn D. 1993. Lactation: historical patterns and potential for manipulation. J. Dairy Sci. 76:3195-212
14. Blank D, Dotz V, Geyer R, Kunz C. 2012. Human milk oligosaccharides and Lewis blood group: individual high-throughput sample profiling to enhance conclusions from functional studies. Adv. Nutr. 3:440-49S
15. Bode L. 2012. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22:1147-62
16. Bode L, Beermann C, Mank M, Kohn G, Boehm G. 2004. Human and bovine milk gangliosides differ in their fatty acid composition. J. Nutr. 134:3016-20
17. Bode L, Jantscher-Krenn E. 2012. Structure-function relationships of human milk oligosaccharides. Adv. Nutr. 3:383-91S
18. Born T, Falk P, Roth KA, Larson G, Normark S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262:1892-95
19. Brandtzaeg P. 2010. The mucosal immune system and its integration with the mammary glands. J. Pediatr. 156:S8-15
20. Bricarello DA, Smilowitz JT, Zivkovic AM, German JB, Parikh AN. 2011. Reconstituted lipoprotein: a versatile class of biologically-inspired nanostructures. ACS Nano 5:42-57
21. Br?numH, Seested T,Hellgren L, Brix S, Fr?i? H. 2005. Milk-derived GM3 and GD3 differentially inhibit dendritic cell maturation and effector functionalities. Scand. J. Immunol. 61:551-57
22. Bu H, Zuo X, Wang X, Ensslin MA, Koti V, et al. 2007. Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J. Clin. Invest. 117:3673-83
23. Charlwood J, Hanrahan S, Tyldesley R, Langridge J, Dwek M, Camilleri P. 2002. Use of proteomic methodology for the characterization of human milk fat globular membrane proteins. Anal. Biochem. 301:314-24
24. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, et al. 2001. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 11:365-72
25. Chaturvedi P, Warren CD, Buescher CR, Pickering LK, Newburg DS. 2001. Survival of human milk oligosaccharides in the intestine of infants. In Bioactive Components of Human Milk, ed. DS Newburg, pp. 315-24. New York: Springer
26. Chen Q, Cao J, Jia Y, LiuX, Yan Y, Pang G. 2012. Modulation ofmice fecal microbiota by administration of casein glycomacropeptide. Microbiol. Res. 3:e3
27. Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. 2012. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J. Pediatr. Gastroenterol. Nutr. 55:321-27
28. Chirico G, Marzollo R, Cortinovis S, Fonte C, Gasparoni A. 2008. Antiinfective properties of human milk. J. Nutr. 138:1801-6S
29. Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, et al. 2008. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes. Diabetes Care 31:340-46
30. Coppa G, Pierani P, Zampini L, Bruni S, Carloni I, Gabrielli O. 2001. Characterization of oligosaccharides in milk and feces of breast-fed infants by high-performance anion-exchange chromatography. In Bioactive Components of Human Milk, ed. DS Newburg, pp. 307-14. New York: Springer
31. Coppa GV, Gabrielli O, Pierani P, Catassi C, Carlucci A, Giorgi PL. 1993. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics 91:637-41
32. Coppa GV, Pierani P, Zampini L, Bruni S, Carloni I, Gabrielli O. 2001. Characterization of oligosaccharides in milk and feces of breast-fed infants by high-performance anion-exchange chromatography. Adv. Exp. Med. Biol. 501:307-14
33. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, et al. 2006. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr. Res. 59:377-82
34. De Leoz ML, Wu S, Strum JS, Ninonuevo MR, Gaerlan SC, et al. 2013. A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Anal. Bioanal. Chem. 405:4089-105
35. De Leoz MLA, Gaerlan SC, Strum JS, Dimapasoc LM, Mirmiran M, et al. 2012. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in humanmilk oligosaccharides from women delivering preterm. J. Proteome Res. 11:4662-72
36. Desai PT, WalshMK, Weimer BC. 2008. Solid phase capture of pathogenic bacteria using gangliosides and detection with real time PCR. Appl. Environ. Microbiol. 74:2254-58
37. Dodds ED, Seipert RR, Clowers BH, German JB, Lebrilla CB. 2009. Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics. J. Proteome Res. 8:502-12
38. DuX-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, et al. 2000. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. 97:12222-26
39. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. 2000. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am. J. Clin. Nutr. 71:1589-96
40. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, et al. 2008. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G1025-34
41. Falk P, Roth KA, Boren T, Westblom TU, Gordon JI, Normark S. 1993. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage specific tropism in the human gastric epithelium. Proc. Natl. Acad. Sci. USA 90:2035-39
42. Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, et al. 2009. A natural history of FUT2 polymorphism in humans. Mol. Biol. Evol. 26:1993-2003
43. Fong B, Ma K, McJarrow P. 2011. Quantification of bovine milk oligosaccharides using liquid chromatography-selected reaction monitoring-mass spectrometry. J. Agric. Food Chem. 59:9788-95
44. Froehlich J, Dodds E, Barboza M, McJimpsey E, Seipert R, et al. 2010. Glycoprotein expression in human milk during lactation. J. Agric. Food Chem. 58:6440-48
45. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543-47
46. Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, et al. 2011. Preterm milk oligosaccharides during the first month of lactation. Pediatrics 128:e1520-31
47. Ganguli K,MengD, Rautava S, Lu L, Walker WA,Nanthakumar N. 2013. Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 304:G132-41
48. Garrido D, Barile D, Mills DA. 2012. A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract. Adv. Nutr. 3:415-21S
49. Garrido D, Kim JH, German JB, RaybouldHE, Mills DA. 2011. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS ONE 6:e17315
50. Garrido D, Nwosu C, Ruiz-Moyano S, Aldredge D, German JB, et al. 2012. Endo-?-Nacetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins. Mol. Cell Proteomics 11:775-85
51. Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom HJ, Block DE, Mills DA. 2013. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol. 33:262-70
52. Garrido D, Ruiz-Moyano S, Mills DA. 2012. Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe 18:430-35
53. Georgieff M, Petry C, Mills M, McKay H, Wobken J. 1997. Increased N-glycosylation and reduced transferrin-binding capacity of transferrin receptor isolated from placentae of diabetic women. Placenta 18:563-68
54. Gordon JI, Dewey KG, Mills DA, Medzhitov RM. 2012. The human gut microbiota and undernutrition. Sci. Transl. Med. 4:137ps12
55. Grollman EF, Ginsburg V. 1967. Correlation between secretor status and the occurrence of 2- fucosyllactose in human milk. Biochem. Biophys. Res. Commun. 28:50-53
56. Gross SJ, Geller J, Tomarelli R. 1981. Composition of breast milk from mothers of preterm infants. Pediatrics 68:490-93
57. Gyorgy P, Norris RF, Rose CS. 1954. Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch. Biochem. Biophys. 48:193-201
58. HaarmanM,Knol J. 2005. Quantitative real-timePCRassays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 71:2318-24
59. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182-87
60. Hanson LA. 1998. Breastfeeding provides passive and likely long-lasting active immunity. Ann. Allergy Asthma Immunol. 81:523-37
61. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, et al. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30:61-67
62. Hebert LF Jr, Daniels MC, Zhou J, Crook ED, Turner RL, et al. 1996. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J. Clin. Invest. 98:930-36
63. Hernandez-Hernandez O, Sanz ML, Kolida S, Rastall RA, Moreno FJ. 2011. In vitro fermentation by human gut bacteria of proteolytically digested caseinomacropeptide nonenzymatically glycosylated with prebiotic carbohydrates. J. Agric. Food Chem. 59:11949-55
64. Hong P, Ninonuevo MR, Lee B, Lebrilla C, Bode L. 2009. Human milk oligosaccharides reduce HIV- 1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN). Br. J. Nutr. 101:482-86
65. Huang P,Xia M, TanM,ZhongW,WeiC, et al. 2012. Spike protein VP8? of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J. Virol. 86:4833-43
66. Ip S, ChungM, Raman G, Chew P, Magula N, et al. 2007. Breastfeeding and maternal and infant health outcomes in developed countries. Evid. Rep. Technol. Assess. 153:1-186
67. Iwamori M, Takamizawa K, Momoeda M, Iwamori Y, Taketani Y. 2008. Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin. Glycoconj. J. 25:675-83
68. Jantscher-Krenn E, Lauwaet T, Bliss LA, Reed SL, Gillin FD, Bode L. 2012. Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro. Br. J. Nutr. 108:1839-46
69. Kavanaugh DW, O'Callaghan J, Butt ? LF, Slattery H, Lane J, et al. 2013. Exposure of Bifidobacterium longum subsp. infantis to milk oligosaccharides increases adhesion to epithelial cells and induces a substantial transcriptional response. PLoS ONE 8:e67224
70. Kim W-S, Ohashi M, Tanaka T, Kumura H, Kim G-Y, et al. 2004. Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp. Biometals 17:279-83
71. Kitaoka M. 2012. Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Adv. Nutr. 3:422-29S
72. Kiyohara M, Nakatomi T, Kurihara S, Fushinobu S, Suzuki H, et al. 2012. N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway. J. Biol. Chem. 287:693-700
73. KumarR,Ouyang F, Story RE, Pongracic JA, Hong X, et al. 2009. Gestational diabetes, atopic dermatitis, and allergen sensitization in early childhood. J. Allergy Clin. Immunol. 124:1031-38.e4
74. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 20:699-722
75. LeeCL, Chiu PCN, Pang PC,Chu IK,Lee KF, et al. 2011. Glycosylation failure extends to glycoproteins in gestational diabetes mellitus. Diabetes 60:909-17
76. Lee H, An HJ, Lerno LA, German JB, Lebrilla CB. 2011. Rapid profiling of bovine and human milk gangliosides by matrix-assisted laser desorption/ ionization Fourier transform ion cyclotron resonance mass spectrometry. Int. J. Mass Spectrom. 305:138-50
77. Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, Mazurier J. 2008. Lactoferrin structure and functions. Adv. Exp. Med. Biol. 606:163-94
78. Liao Y, Alvarado R, Phinney B, L?onnerdal B. 2011. Proteomic characterization of human milk whey proteins during a twelve-month lactation period. J. Proteome Res. 10:1746-54
79. Liepke C, Adermann K, RaidaM,Mgert HJ, Forssmann WG, Zucht HD. 2002. Human milk provides peptides highly stimulating the growth of bifidobacteria. Eur. J. Biochem. 269:712-18
80. Lin H-C, Hsu C-H, Chen H-L, Chung M-Y, Hsu J-F, et al. 2008. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122:693-700
81. Lin H-C, Su B-H, Chen A-C, Lin T-W, Tsai C-H, et al. 2005. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115:1-4
82. LoCascio R, Ninonuevo M, Freeman S, Sela D, Grimm R, et al. 2007. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J. Agric. Food Chem. 55:8914-19
83. Locascio RG, Ninonuevo MR, Kronewitter SR, Freeman SL, German JB, et al. 2009. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb. Biotechnol. 2:333-42
84. Lonnerdal B. 2010. Bioactive proteins in human milk: mechanisms of action. J. Pediatr. 156:S26-30
85. Marcobal A, Barboza M, Froehlich J, Block D, German JB, et al. 2010. Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food Chem. 58:5334-40
86. Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, et al. 2011. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 10:507-14
87. Marth JD, Grewal PK. 2008. Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8:874-87
88. Martin-Sosa S, Martin MJ, Hueso P. 2002. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J. Nutr. 132:3067-72
89. Mechref Y, Chen P, Novotny MV. 1999. Structural characterization of the N-linked oligosaccharides in bile salt-stimulated lipase originated from human breast milk. Glycobiology 9:227-34
90. Molinari CE, Casadio YS, Hartmann BT, Arthur PG, Hartmann PE. 2013. Longitudinal analysis of protein glycosylation and ?-casein phosphorylation in term and preterm human milk during the first 2 months of lactation. Br. J. Nutr. 110:105-15
91. Molinari CE, Casadio YS, Hartmann BT, Livk A, Bringans S, et al. 2012. Proteome mapping of human skim milk proteins in term and preterm milk. J. Proteome Res. 11:1696-714
92. Morrow AL, Meinzen-Derr J, Huang P, Schibler KR, Cahill T, et al. 2011. Fucosyltransferase 2 nonsecretor and low secretor status predicts severe outcomes in premature infants. J. Pediatr. 158:745-51
93. Morrow AL, Ruiz-PalaciosGM, JiangX,NewburgDS. 2005. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J. Nutr. 135:1304-7
94. Newburg DS. 2013. Glycobiology of human milk. Biochemistry (Moscow) 78:771-85
95. NewburgDS, Ruiz-PalaciosGM, Morrow AL. 2005. Humanmilk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 25:37-58
96. Newburg DS, Walker WA. 2007. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr. Res. 61:2-8
97. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, et al. 2006. A strategy for annotating the human milk glycome. J. Agric. Food Chem. 54:7471-80
98. Ninonuevo MR, Perkins PD, Francis J, Lamotte LM, LoCascio RG, et al. 2008. Daily variations in oligosaccharides of human milk determined by microfluidic chips and mass spectrometry. J. Agric. Food Chem. 56:618-26
99. Ninonuevo MR,Ward RE, LoCascio RG, German JB, Freeman SL, et al. 2007. Methods for the quantitation of human milk oligosaccharides in bacterial fermentation by mass spectrometry. Anal. Biochem. 361:15-23
100. Nusrat A, Turner J, Madara J. 2000. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279:G851-57
101. Nwosu CC, Huang J, Aldredge DL, Strum JS, Hua S, et al. 2012. In-gel nonspecific proteolysis for elucidating glycoproteins: a method for targeted protein-specific glycosylation analysis in complex protein mixtures. Anal. Chem. 85:956-63
102. OchoaTJ, Noguera-ObenzaM, Ebel F,GuzmanCA, GomezHF, Cleary TG. 2003. Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 71:5149-55
103. Oda H, Wakabayashi H, Yamauchi K, Sato T, Xiao J-Z, et al. 2013. Isolation of a bifidogenic peptide from the pepsin hydrolysate of bovine lactoferrin. Appl. Environ. Microbiol. 79:1843-49
104. Pan XL, Izumi T. 2000. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum. Dev. 57:25-31
105. Peterson R, CheahWY, Grinyer J, Packer N. 2013. Glycoconjugates in human milk: protecting infants from disease. Glycobiology 23:1425-38
106. Petshow BW, Talbottt RD, Batema RP. 1999. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level. J. Med. Microbiol. 48:541-49
107. Qiu J, Hendrixson DR, Baker EN, Murphy TF, Geme JWS, Plaut AG. 1998. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc. Natl. Acad. Sci. 95:12641-46
108. Reinhold V, Zhang H, Hanneman A, Ashline D. 2013. Toward a platform for comprehensive glycan sequencing. Mol. Cell. Proteomics 12:866-73
109. Roger LC, McCartney AL. 2010. Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 156:3317-28
110. Rueda R. 2007. The role of dietary gangliosides on immunity and the prevention of infection. Br. J. Nutr. 98:S68-73
111. Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, et al. 2013. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Appl. Environ. Microbiol. 79:6040-49
112. RumboM, Schiffrin EJ. 2005. Ontogeny of intestinal epithelium immune functions: developmental and environmental regulation. Cell Mol Life Sci 62:1288-96
113. Ruvon-ClouetN,LePendu J, MasE,Marionneau S, GuillonP, LombardoD. 2006. Bile-salt-stimulated lipase and mucins from milk of "secretor" mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem. J 393:627-34
114. Sakata S, Tonooka T, Ishizeki S, Takada M, Sakamoto M, et al. 2005. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiol. Lett. 243:417-23
115. Schroten H, Stapper C, Plogmann R, K?ohler H, Hacker J, Hanisch FG. 1998. Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides. Infect. Immun. 66:3971-73
116. Seipert RR, Dodds ED,Clowers BH, Beecroft SM,German JB, Lebrilla CB. 2008. Factors that influence fragmentation behavior of N-linked glycopeptide ions. Anal. Chem. 80:3684-92
117. Sela DA, Chapman J, Adeuya A, Kim J, Chen F, et al. 2008. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. USA 105:18964-69
118. Sela DA, Garrido D, Lerno L, Wu S, Tan K, et al. 2012. Bifidobacterium longum subsp. infantis ATCC 15697 ?-fucosidases are active on fucosylated human milk oligosaccharides. Appl. Environ. Microbiol. 78:795-803
119. Sela DA, Li Y, Lerno L, Wu S, Marcobal AM, et al. 2011. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J. Biol. Chem. 286:11909-18
120. Shen L, Grollman EF, Ginsburg V. 1968. An enzymatic basis for secretor status and blood group substance specificity in humans. Proc. Natl. Acad. Sci. USA 59:224-30
121. Shen Z, Warren CD, Newburg DS. 2000. High-performance capillary electrophoresis of sialylated oligosaccharides of human milk. Anal. Biochem. 279:37-45
122. Smilowitz JT, O'Sullivan A, Barile D, German JB, Lonnerdal B, Slupsky CM. 2013. The human milk metabolome reveals diverse oligosaccharide profiles. J. Nutr. 143:1709-18
123. Smilowitz JT, Totten SM, Huang J, Grapov D, Durham HA, et al. 2013. Human milk secretory immunoglobulin A and lactoferrin N-glycans are altered in women with gestational diabetes mellitus. J. Nutr. 143:1906-12
124. Strum JS, Kim J, Wu S, De Leoz ML, Peacock K, et al. 2012. Identification and accurate quantitation of biological oligosaccharide mixtures. Anal. Chem. 84:7793-801
125. Strum JS, Nwosu CC, Hua S,Kronewitter SR, Seipert RR, et al. 2013. Automated assignments ofN- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures. Anal. Chem. 85:5666-75
126. Tao N, Ochonicky KL, German JB, Donovan SM, Lebrilla CB. 2010. Structural determination and daily variations of porcine milk oligosaccharides. J. Agric. Food Chem. 58:4653-59
127. Tao N, Wu S, Kim J, An HJ, Hinde K, et al. 2011. Evolutionary glycomics: characterization of milk oligosaccharides in primates. J. Proteome Res. 10:1548-57
128. Thakkar SK, Giuffrida F, Cristina CH, Castro CA, Mukherjee R, et al. 2013. Dynamics of human milk nutrient composition of women from Singapore with a special focus on lipids. Am. J. Hum. Biol. 25:770-79
129. Thurl S, Munzert M, Henker J, Boehm G, Muller-Werner B, et al. 2010. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br. J. Nutr. 104:1261-71
130. Tissier H. 1900. Recherches sur la flore intestinale des nourrissons: etat normal et pathologique. Paris: G. Carr? et C. Naud
131. Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, et al. 2012. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J. Proteome Res. 11:6124-33
132. Tseng K, Hedrick JL, Lebrilla CB. 1999. Catalog-library approach for the rapid and sensitive structural elucidation of oligosaccharides. Anal. Chem. 71:3747-54
133. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, et al. 2010. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc. Natl. Acad. Sci. USA 107:19514-19
134. Turroni F, Van Sinderen D, VenturaM. 2011. Genomics and ecological overview of the genus Bifidobacterium. Int. J. Food Microbiol. 149:37-44
135. Uchiyama S-i, Sekiguchi K, Akaishi M, Anan A, Maeda T, Izumi T. 2011. Characterization and chronological changes of preterm human milk gangliosides. Nutrition 27:998-1001
136. Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, et al. 2013. A comparison of two probiotic strains of bifidobacteria in premature infants. J. Pediatr. 163:1585-91
137. Van Berkel P, Geerts M, Van Veen H, Kooiman P, Pieper F, et al. 1995. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis. Biochem. J. 312:107-14
138. Van Berkel P, Van Veen H, Geerts M, De Boer H, Nuijens J. 1996. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem. J. 319:117-22
139. vanVeen H, Geerts M, vanBerkel P,Nuijens J. 2004. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. Eur. J. Biochem. 271:678-84
140. Varki A. 2011. Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells. Cold Spring Harb. Perspect. Biol. 3:6
141. Wang Y-Z, Shan T-Z, Xu Z-R, Feng J, Wang Z-Q. 2007. Effects of the lactoferrin (LF) on the growth performance, intestinal microflora and morphology of weanling pigs. Anim. Feed Sci. Technol. 135:263-72
142. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. 2006. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl. Environ. Microbiol. 72:4497-99
143. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. 2007. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol. Nutr. Food Res. 51:1398-405
144. Weber A, Loui A, Jochum F, Buhrer C, Obladen M. 2001. Breast milk from mothers of very low birthweight infants: variability in fat and protein content. Acta Paediatr. 90:772-75
145. Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg RM. 2006. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin. Nutr. 25:361-68
146. Wold AE,Mestecky J, TomanaM, Kobata A, Ohbayashi H. 1990. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58:3073-77
147. WuS, TaoN,German JB, Grimm R, Lebrilla CB. 2010. Development of an annotated library of neutral human milk oligosaccharides. J. Proteome Res. 9:4138-51
148. WuSA,Grimm R, German JB, Lebrilla CB. 2011. Annotation and structural analysis of sialylated human milk oligosaccharides. J. Proteome Res. 10:856-68
149. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, et al. 2012. Human gut microbiome viewed across age and geography. Nature 486:222-27
150. Yu Z-T, Chen C, Kling DE, Liu B, McCoy JM, et al. 2013. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 23:169-77
151. Zauner G, Selman MHJ, Bondt A, Rombouts Y, Blank D, et al. 2013. Glycoproteomic analysis of antibodies. Mol. Cell. Proteomics 12:856-65
152. Zivkovic AM, Lewis ZT, German JB, Mills DA. 2013. Establishment of a milk-oriented microbiota (MOM) in early life: how babies meet their MOMs. Funct. Food Rev. 5:3-12